ArticleFrontiers in oncology2022

Case report: Success of tepotinib therapy in overcoming resistance to osimertinib in a patient with EGFR-mutant lung adenocarcinoma with a potential acquired MET exon 14 skipping mutation.

Shinkichi Takamori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.